Navigation Links
HMS Holdings Corp. Hosts Third Quarter 2007 Financial Teleconference and Presentation
Date:10/15/2007

NEW YORK, Oct. 15 /PRNewswire-FirstCall/ -- HMS Holdings Corp. (Nasdaq: HMSY) today announced it will host a webcast and conference call at 10 am ET on Friday, November 2, 2007 to discuss the financial results for the third quarter 2007, which ended September 30. Financial results are scheduled for release after the market closes on Thursday, November 1, 2007.

WHO: Robert Holster, Chairman and CEO

WHEN: Friday, November 2, 2007

10:00 AM ET

HOW: Presentation:

To view the presentation, please copy and paste the following

link into your browser:

http://www.hmsholdings.com/news/quarterly_reports.asp

Conference Call:

To participate in the conference call, please dial:

US/Canada: 1 (877) 272-8639

Int'l/Local Dial-In: (706) 634-1355

Participant Code: 20688907

REPLAY: A conference call replay will be available beginning 11/02/2007

11:00 AM ET through 11/9/2007 11:00 PM ET. To listen to the

replay of the call, dial:

US/Canada: (800) 642-1687

Int'l/Local Dial-In: (706) 645-9291

Participant Code: 20688907

or visit our website at

http://www.hmsholdings.com/news/quarterly_reports.asp

HMS Holdings Corp. is a national leader in cost containment and program integrity services for government healthcare programs. In 2006, HMS recovered more than $1.0 billion from third parties and other funding sources for its clients, and provided data that assisted them in saving billions more. HMS serves more than 70 Medicaid managed care plans and the Medicaid programs of 40 states. HMS Holdings Corp (Nasdaq:

SOURCE HMS Holdings Corp.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Oracle Corp. to help build worlds first "Digital Hospital"
2. Chennai Plays Hosts To The Diabetes World Congress
3. Chennai Plays Hosts To The Diabetes World Congress
4. AMSA Hosts International Health Conference
5. Mutant Parasites, Unable to Infect Hosts, Highlight Virulence Genes
6. AMSA Hosts Largest Medical Student Conference in Southern Hemisphere
7. Imphal Hosts Cycle Rally to Spread Drug Abuse Awareness
8. Robot Hosts South Korean Wedding
9. Third artificial heart patient introduced
10. Extra hormone found to cut appetite by a third
11. Third generation Small pox vaccine from Cell-culture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...-USNewswire/ -- The Custom Briefings,network of Bu...e Endocrine,Daily Briefing, produced exclusively f...y., Endocrine Daily Briefing is emailed Monday th...ers, medical professionals engaged in the,fight ag...Endocrine Daily,Briefing joins a network of medica...
(Date:8/29/2008)...USNewswire/ -- The following is a,statement by Mat...e Kids:, For the second time in a month, Philip M...p and promotion of a concert in a developing count...engaging in cigarette,marketing that appeals to ch...as been forced to withdraw from,an August 30 reuni...
(Date:8/29/2008)...swire-FirstCall/ -- InterMune, Inc.,(Nasdaq: ITMN... CEO and,President of InterMune, will present at t... Boston on September 4, 2008 at 10:55 a.m. EDT., ..., investors and other,interested parties may log o...rporate website at http://www.intermune.com . The...
(Date:8/29/2008)...re Than 30 European Countries, HONOLULU, Aug. 29 ...y,that it has successfully completed the intensive...evice Directive (for most European Union countries...or Conformite Europeene Mark,-- for the LifeBed(TM...atient safety reach to include more than 30 countr...
Breaking Medicine News(10 mins):Health News:Custom Briefings Announces Launch of Endocrine Daily Briefing 2Health News:Philip Morris International Forced to Drop Another Concert Sponsorship; Philippines Health Department Applauded for Taking Action 2Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 2Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 3Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 4
...ng too many high-fat meals will clog arteries and ...ews that even a single high-fat meal can quickly s...ate pumping up of blood pressure levels could prov...rough which high fat meals produce heart disease o...
...ished in PLoS Medicine journal by Cambridge rese...t which a woman first menstruates.// These are he...eight and risk of obesity in later life. Research...ouncil and University of Cambridge, led by Dr Ken ...
...omen who drink more two bottles of wine over the w...breast cancer. // The study reported in the Europ...p of 17,647 nurses who drank 22-27 drinks a week c...e drinks, the risk of breast cancer was two times ...
...ble searing feeling in your stomach and chest, is ...According to researchers, modern day life with its...r sleep necessitates the purchase of fast foods an... root cause of the problem, they say. A study co...
Other Medicine News:Health News:A Single High Fat Meal Could Boost Blood Pressures 2Health News:Women Binge- Drinkers Warned Of Possible Link To Breast Cancer 2Health News:Heartburn Shadowing Modern India 2
(Date:8/25/2008)...Y HILLS, Mass., Aug. 25 /- Joseph F. ... of Spherics, Inc. ("Spherics") for,the benefit of...l,intellectual property will be sold at a sealed b...tended release formulation of Levodopa-Carbidopa t...kinson,s disease, with global,sales estimated at a...
(Date:8/25/2008)...O, Calif., Aug. 25 /- Anthera Pharmac...company developing,anti-inflammatory drugs, today ...urrent Acute coronary events with Near-term Cardio...designed to examine the impact of,varespladib when...ute,Coronary Syndrome (ACS) event., The FRANCIS t...
(Date:8/22/2008)...men Enrolled in Trial Sponsored by Medical Researc...FirstCall/ -- Indevus,Pharmaceuticals, Inc. (Nasda...lment in Protocol MDP 301, a Phase III clinical tr...icrobicide for the prevention of HIV and other,sex...ed by the United,Kingdom,s Medical Research Counci...
(Date:8/22/2008)...E, Md., Aug. 22 /- Human Ge...ed that it has completed the,enrollment and initia... of,HGS-ETR1 (mapatumumab) in combination with the... first-line therapy in advanced non-small cell,lun.../cgi-bin/prnh/20080416/HGSLOGO ), "There is an u...
Breaking Medicine Technology:Spherics, Inc. Offers Extended Release Formulation for Sustained and Stable Levodopa Levels 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 2Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 4Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 5Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 2Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 3Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 4Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 5RIVAs Cutting Edge Technology To Help Intermountain Healthcare Enhance Medication Delivery Safety 14295 1RIVAs Cutting Edge Technology To Help Intermountain Healthcare Enhance Medication Delivery Safety 14295 2HRSA Launches Digital Campaign to Promote Poison Awareness and Prevention 14292 1HRSA Launches Digital Campaign to Promote Poison Awareness and Prevention 14292 22007 Procedural Survey Reveals a Two Year Increase in Age of Patients Seeking Cosmetic Surgery 14289 12007 Procedural Survey Reveals a Two Year Increase in Age of Patients Seeking Cosmetic Surgery 14289 2Rodent study finds artificial butter chemical harmful to lungs 14287 1Rodent study finds artificial butter chemical harmful to lungs 14287 2
...Maintained Improvement in Personal and Social,Pe...07 /PRNewswire/ --,Longer-term treatment with IN..., a new once daily oral medication for,schizophr...ir,symptoms and maintain their improvements in p... data are from a large, open label, international,...
...nforce Astellas Commitment to Overcoming Critical,...many, April 02, 2007 /PRNewswire/ --Study results,...l Microbiology,and Infectious Diseases (ECCMID) sh...gal micafungin, both have the potential,to meet a ...s,hospital-acquired infections (HAIs). , Hospital-...
Other Medicine Technology:Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 2Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 3Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 4Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 5Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 6Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 2Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 3Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 4Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 5
The new PERIMOUNT Magna heart valve (bioprosthesis), with its true supra-annular design, offers optimal hemodynamics and flow characteristics for treatment of aortic heart valve disease.
... in high performance ultrasound design provides un...Echocardiography imaging requires superior spatial...er performance. The Terason Echo Ultrasound System...ecture, delivers a compact imaging platform withou...
...mplified In-office. Information. In real time. The...definitive indications of elevated vaginal fluid p...The innovative format is easy to use and delivers ...rub a swab containing unprocessed vaginal fluid ac...
For the quantitative determination of human MMP-9/NGAL Complex concentrations in cell culture supernates, serum,plasma, urine and saliva.
Medicine Products: